http://www.avrobio.com
AVROBIO, Inc. Company Intro
Our gene therapies are designed to halt or reverse progression of lysosomal disorders with a single infusion. Learn about us, our focus and technology, sign up for updates, and read articles to expand your gene therapy knowledge.
Industry
Healthcare
AVROBIO, Inc. Headquaters
Building 300
Cambridge,02139
United States
AVROBIO, Inc. Share price
14 Sep 2022 08:41 GMT
$0.8601
-0.02 (-2.74 %)
AVROBIO, Inc. Market cap
$37.759 M
WMC RANKING
2023
AVROBIO, Inc. # 347
BiotechnologyLatest AVROBIO, Inc. News
24 Mar 2023
What To Expect Going Ahead For AVROBIO Inc. (NASDAQ ...
During the last session, AVROBIO Inc. (NASDAQ:AVRO)'s traded shares were 1.82 million, with the beta value of the company hitting 1.63.
24 Mar 2023
Pompe Disease Enzyme Replacement Therapy Market ...
Pompe Disease Enzyme Replacement Therapy Market ...
24 Mar 2023
What To Expect Going Ahead For AVROBIO Inc. (NASDAQ ...
During the last session, AVROBIO Inc. (NASDAQ:AVRO)'s traded shares were 1.82 million, with the beta value of the company hitting 1.63.
WMC Market Score
WMC Market to Revenue Score
AVROBIO, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| AVROBIO, Inc. | USD | $0 | $120,523 | $-120,638 | $378M | 347 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total AVROBIO, Inc. Social Followers vs Top 4 Industry Competitors
AVROBIO, Inc. Post vs Top 4 Industry Competitors
AVROBIO, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
AVROBIO, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
AVROBIO, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| AVROBIO, Inc. | 0 | 5.95 | 0.09 | 0 | 0 | 0 | 2.72 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 22 | 0 | 0 | 28.52 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 33 | 0 | 0 | 34.78 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
